Hosenpud J D, Breen T J, Edwards E B, Daily O P, Hunsicker L G
Research Department, United Network for Organ Sharing, Richmond, VA.
JAMA. 1994 Jun 15;271(23):1844-9.
The number of cardiac transplant programs continues to increase despite no increase in the number of hearts available for transplantation. As a result, the majority of heart transplant centers perform extremely small numbers of transplant operations annually. To determine the effect of small transplantation volume on transplant outcome, the following study was performed.
Using the Scientific Registry of the United Network for Organ Sharing, all cardiac transplant procedures from October 1987 through December 1991 were analyzed to determine whether center volumes affected cardiac transplant outcome. Patient survival rates for each center were determined, and the survival rates were modeled for the following patient variables: first transplantation or retransplantation, patient condition at the time of transplantation, patient underlying cardiac disease (congenital vs all others), and time.
All cardiac transplant centers in the United States were included in the analysis.
All patients undergoing cardiac transplantation in the United States from October 1987 through December 1991 were included in the analysis.
The primary end point in this analysis was mortality.
Throughout the entire study, of the 150 cardiac transplant centers, 35.3% of the centers were performing fewer than five cardiac transplantations per year, 53.3% were performing fewer than nine transplantations per year, and 61.3% were performing fewer than 12 transplantations per year, the minimum required for Medicare payment eligibility. Using the modeled survival rates, the risk of mortality decreased to a basal level in those centers performing between eight and 10 transplant operations per year. In centers performing fewer than nine transplantations, mortality increased sharply and exponentially. Dividing centers into those that performed nine or more transplantations per year (70 centers) and fewer than nine transplantations per year (80 centers), the increased risk of mortality at 1 month and 12 months was 40.3% and 33.1%, respectively, in centers performing fewer than nine cardiac transplantations per year (P < .001). Once the threshold of nine transplant procedures was met, those centers that were eligible for Medicare payment did not have significantly better survival than those centers not eligible for Medicare coverage.
These data demonstrate that the risk of mortality at early and intermediate time points is substantially higher in low-volume cardiac transplant centers, which make up more than half of the centers performing cardiac transplantation in the United States.
尽管可用于移植的心脏数量未增加,但心脏移植项目的数量仍在持续增长。因此,大多数心脏移植中心每年进行的移植手术数量极少。为确定小移植量对移植结果的影响,进行了以下研究。
利用器官共享联合网络科学注册系统,分析了1987年10月至1991年12月期间所有的心脏移植手术,以确定中心手术量是否会影响心脏移植结果。确定了每个中心的患者生存率,并针对以下患者变量对生存率进行建模:首次移植或再次移植、移植时的患者状况、患者潜在的心脏病(先天性与其他所有类型)以及时间。
分析纳入了美国所有的心脏移植中心。
纳入了1987年10月至1991年12月期间在美国接受心脏移植的所有患者。
该分析的主要终点是死亡率。
在整个研究期间,150个心脏移植中心中,35.3%的中心每年进行的心脏移植手术少于5例,53.3%的中心每年进行的移植手术少于9例,61.3%的中心每年进行的移植手术少于12例,而12例是获得医疗保险支付资格所需的最低手术量。根据建模的生存率,每年进行8至10例移植手术的中心,死亡风险降至基础水平。在每年进行少于9例移植手术的中心,死亡率急剧上升且呈指数增长。将中心分为每年进行9例或更多移植手术的中心(70个)和每年进行少于9例移植手术的中心(80个),每年进行少于9例心脏移植手术的中心在1个月和12个月时死亡风险增加分别为40.3%和33.1%(P <.001)。一旦达到9例移植手术的阈值,那些有资格获得医疗保险支付的中心的生存率并不比那些没有资格获得医疗保险覆盖的中心显著更好。
这些数据表明,在美国进行心脏移植的中心中,超过一半是低手术量的心脏移植中心,其在早期和中期时间点的死亡风险显著更高。